BSE filing, NSE: VASUPRADA. Summary written from the filing by ALFA Finder's alert engine.
Shri Vasuprada Plantations Ltd: key numbers
- Share price
- ₹95.00
- Market cap
- ₹78.70 Cr
- Revenue (annual)
- ₹143.6 Cr
- Net profit (annual)
- ₹-7.12 Cr
- P/E (TTM)
- -19.8×Sector 26.8×
- Promoter holding
- 74.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shri Vasuprada Plantations Ltd
All →Shri Vasuprada Plantations Board Meeting Date
Shri Vasuprada Plantations will hold its Board of Directors meeting on 02/11/2026. The agenda includes approval of unaudited standalone and consolidated Q2/half-year results ending 30/09/2026.
Shri Vasuprada Plantations Debt & Borrowing: ₹1.04 Cr
Shri Vasuprada Plantations certified timely payment of interest on its 9% Secured NCDs. The interest paid was Rs.1.04 Crore (gross) for the period due 21/09/2026.
- Value
- ₹1.04 Cr
Shri Vasuprada Plantations Annual General Meeting
Shri Vasuprada Plantations Ltd held its 152nd Annual General Meeting on 31st August, 2026. The company transacted ordinary and special business items as per the notice.
Shri Vasuprada Plantations Other Announcement
Shri Vasuprada Plantations informed that preference shareholders have acquired voting rights for the upcoming AGM due to three years of unpaid dividends on these shares.
Shri Vasuprada Plantations Annual Report
Shri Vasuprada Plantations Ltd filed its Annual Report for the financial year ended March 31, 2026, including the Notice for the upcoming Annual General Meeting.
Shri Vasuprada Plantations Annual General Meeting
Shri Vasuprada Plantations Limited has issued a notice for its 152nd Annual General Meeting, scheduled for August 31, 2026, to be held via video conferencing.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.